Wnt/β-catenin-pathway as a molecular tar
✍
Susanne Dihlmann; Magnus von Knebel Doeberitz
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
French
⚖ 213 KB
Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit, regarding survival time not to mention cure of the patients. To improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Colorectal